CA1102790A - 3,7-disubstituted cephalosporins and preparation thereof - Google Patents

3,7-disubstituted cephalosporins and preparation thereof

Info

Publication number
CA1102790A
CA1102790A CA278,851A CA278851A CA1102790A CA 1102790 A CA1102790 A CA 1102790A CA 278851 A CA278851 A CA 278851A CA 1102790 A CA1102790 A CA 1102790A
Authority
CA
Canada
Prior art keywords
acid
cephem
carboxylic acid
amino
chemical equivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA278,851A
Other languages
English (en)
French (fr)
Inventor
Giorgio Palamidessi
Franco Zarini
Giovanni Franceschi
Federico Arcamone
Giovanna Schioppacassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Application granted granted Critical
Publication of CA1102790A publication Critical patent/CA1102790A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA278,851A 1976-05-21 1977-05-20 3,7-disubstituted cephalosporins and preparation thereof Expired CA1102790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21032/76A GB1579532A (en) 1976-05-21 1976-05-21 Cephalosporins
GB21032/76 1976-05-21

Publications (1)

Publication Number Publication Date
CA1102790A true CA1102790A (en) 1981-06-09

Family

ID=10156029

Family Applications (1)

Application Number Title Priority Date Filing Date
CA278,851A Expired CA1102790A (en) 1976-05-21 1977-05-20 3,7-disubstituted cephalosporins and preparation thereof

Country Status (22)

Country Link
US (1) US4148996A (US20090163788A1-20090625-C00002.png)
JP (1) JPS52142093A (US20090163788A1-20090625-C00002.png)
AT (1) AT355719B (US20090163788A1-20090625-C00002.png)
AU (1) AU509448B2 (US20090163788A1-20090625-C00002.png)
BE (1) BE854845A (US20090163788A1-20090625-C00002.png)
CA (1) CA1102790A (US20090163788A1-20090625-C00002.png)
CH (1) CH639095A5 (US20090163788A1-20090625-C00002.png)
CS (1) CS199676B2 (US20090163788A1-20090625-C00002.png)
DE (1) DE2722666C2 (US20090163788A1-20090625-C00002.png)
DK (1) DK216877A (US20090163788A1-20090625-C00002.png)
FR (1) FR2424922A1 (US20090163788A1-20090625-C00002.png)
GB (1) GB1579532A (US20090163788A1-20090625-C00002.png)
GR (1) GR73013B (US20090163788A1-20090625-C00002.png)
HU (1) HU174072B (US20090163788A1-20090625-C00002.png)
IL (1) IL52123A (US20090163788A1-20090625-C00002.png)
NL (1) NL7705262A (US20090163788A1-20090625-C00002.png)
NO (1) NO771744L (US20090163788A1-20090625-C00002.png)
NZ (1) NZ184110A (US20090163788A1-20090625-C00002.png)
SE (1) SE433851B (US20090163788A1-20090625-C00002.png)
SU (1) SU799669A3 (US20090163788A1-20090625-C00002.png)
YU (1) YU123077A (US20090163788A1-20090625-C00002.png)
ZA (1) ZA772859B (US20090163788A1-20090625-C00002.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004077A1 (en) * 2015-06-29 2017-01-05 Duke University Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
DE2359544A1 (de) * 1973-11-29 1975-10-30 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US3960849A (en) * 1974-03-13 1976-06-01 E. R. Squibb & Sons, Inc. Amino-1,2,4-oxadiazolyl-3-acetyl cephalosporins
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
HU174072B (hu) 1979-10-28
IL52123A0 (en) 1977-07-31
YU123077A (en) 1982-10-31
DE2722666C2 (de) 1982-04-15
NL7705262A (nl) 1977-11-23
JPS52142093A (en) 1977-11-26
ATA348977A (de) 1979-08-15
ZA772859B (en) 1978-04-26
GR73013B (US20090163788A1-20090625-C00002.png) 1984-01-25
GB1579532A (en) 1980-11-19
SE7705934L (sv) 1977-11-22
DK216877A (da) 1977-11-22
FR2424922A1 (fr) 1979-11-30
SU799669A3 (ru) 1981-01-23
CS199676B2 (en) 1980-07-31
BE854845A (fr) 1977-11-21
SE433851B (sv) 1984-06-18
NO771744L (no) 1977-11-22
AU509448B2 (en) 1980-05-15
US4148996A (en) 1979-04-10
CH639095A5 (de) 1983-10-31
AU2507177A (en) 1978-11-16
AT355719B (de) 1980-03-25
FR2424922B1 (US20090163788A1-20090625-C00002.png) 1983-07-08
DE2722666A1 (de) 1977-12-01
NZ184110A (en) 1979-08-31
IL52123A (en) 1980-11-30

Similar Documents

Publication Publication Date Title
CA1072950A (en) Cephalosporin-type antibiotics and process for producing the same
GB2071654A (en) Hydroxamic acid derivatives of 7-(2-amino-4-thiazolyl)oximino cephalosporins
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4104469A (en) 7-(Syn-α-alkoxy-iminofuryl)acetamido-3-(2-methyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4604387A (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, and a procedure for their preparation
CA1102790A (en) 3,7-disubstituted cephalosporins and preparation thereof
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US3814755A (en) 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US4145540A (en) 7β-Phosphoramido-7α-methoxycephalosporanic acid derivatives
US4103085A (en) 7-(Syn-α-alkoxy-iminofurylacetamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US4179502A (en) 7[2-Hydroxyiminoacetamido]cephalosporins
US4138554A (en) 7-[D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-phenyl (and p-hydroxyphenyl)acetamido]-3-carbamoyloxymethyl-3-cephem-4-carboxylic acids
US3998950A (en) 7-αHydrazinoacetamido derivatives of cephalosporanic
CA1068260A (en) 7-(alpha-furoylureidoaryl and cyclohexadieny-lacetamido) cephalosporin antibiotics
US3991051A (en) [(Oxyalkyl)thioacetyl]cephalosporin derivatives
EP0000100B1 (en) 7-acylamino-3-(1-(2-sulfamoylaminoethyl)-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids, a process for their preparation and compositions containing them
US4117124A (en) 7-Acylamino-3-[[3-(carboxymethyl)thio-1H-1,2,4-triazol-5-yl]thiomethyl]-3-cephem-4-carboxylic acids
US4005081A (en) 3-Heterothiomethyl-7α-methoxy-7β-tetrazolylmethylthioacetamido-3-cephem derivatives
JPS6337106B2 (US20090163788A1-20090625-C00002.png)
US3843640A (en) 2-spirocyclopropyl-3-cephem antibiotics
US3910900A (en) 7-(D-a-hydroxy-2-arylacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acids
US3994889A (en) 3-Heterothio derivatives of (α-thiocarbonylaminol)-7α-methoxy-cephalosporins
US3996216A (en) 3-Heterothio derivatives of (formylamino)acetylamino-7-alpha-methoxy cephalosporins
JPS6156238B2 (US20090163788A1-20090625-C00002.png)
JPH093074A (ja) セファロスポリン化合物、その用途および中間体化合物

Legal Events

Date Code Title Description
MKEX Expiry